Michael Monroe
Medical · Dallas, TXNPI 1447383385
Payments from drug & device makers
Across 204 payments — averaging $19.66 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Amgen$606
- Mallinckrodt Hospital Products Inc.$445
- AstraZeneca$267
- Pfizer$261
- Johnson & Johnson$244
- plus $1K from 14 others
What the payments were for
- Food & beverage$3,95099%
- Education$601%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 44 | $1,040 |
| Amgen(2 entities) | 37 | $606 |
| Mallinckrodt Hospital Products Inc. | 25 | $445 |
| AstraZeneca | 12 | $267 |
| Pfizer | 11 | $261 |
| Johnson & Johnson | 16 | $244 |
| E.r. Squibb & Sons, L.L.C. | 12 | $197 |
| Boehringer Ingelheim | 7 | $179 |
| Fresenius Kabi USA, LLC | 7 | $141 |
| Azurity Pharmaceuticals, Inc. | 7 | $124 |
| Organon | 8 | $120 |
| ANI Pharmaceuticals, Inc. | 4 | $97 |
| UCB, Inc. | 3 | $68 |
| Scilex Pharmaceuticals Inc. | 3 | $49 |
| Lilly USA, LLC | 2 | $46 |
| Alvogen Inc | 2 | $37 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $33 |
| Sanofi | 1 | $21 |
| Fidia Pharma USA Inc. | 1 | $19 |
| Kyowa Kirin, Inc. | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- XELJANZ$121
How this compares
$4,010 in reported general payments places this provider in the 80th percentile of 1,490 medical providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Xeljanz XrTofacitinib Citrate | 13 | $72,889 |
| Hydroxychloroquine Sulfate | 101 | $3,106 |
| Sulfasalazine | 37 | $763 |
| MethotrexateMethotrexate Sodium | 45 | $673 |
| Leflunomide | 20 | $667 |
| Gabapentin | 21 | $451 |
| Prednisone | 145 | $436 |
| Folic Acid | 17 | $161 |
Paid to pharmacies, not to this prescriber.
Other medical in Dallas
- Kimberly PoarchDallas$166K
- Erin DuhaimeDallas$150K
- Danny DeckardDallas$101K
- Janine ShinnDallas$84K
- Andrew GarzaDallas$43K
- Alyssa SpiegelDallas$18K
- Jose de la CerdaSan Antonio$1.1M
- Mark DavisFort Worth$1M
- Joey Dixon-JulianBoerne$458K
- Terry FaleyeKingwood$243K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.